Skip to main content

Table 9 Prevalent dialysis patient distribution by age and primary disease

From: Annual Dialysis Data Report 2014, JSDT Renal Data Registry (JRDR)

Primary disease

<5

5~9

10~14

15~19

20~24

25~29

30~34

35~39

40~44

45~49

50~54

55~59

60~64

65~69

70~74

75~79

80~84

85~89

90~94

95

Subtotal

Unspecified

No information on birth date

Total

Mean age

S.D.

Chronic glomerulonephritis

1

4

6

28

71

242

647

1490

3009

4586

5996

8561

13,680

16,778

15,287

12,066

8773

4446

1139

160

96,970

  

96,970

66.54

12.47

(%)

(2.4)

(12.5)

(13.6)

(25.7)

(28.9)

(35.5)

(36.7)

(37.0)

(35.0)

(34.5)

(33.5)

(33.8)

(33.9)

(32.1)

(31.0)

(28.6)

(27.3)

(26.7)

(26.0)

(25.9)

(31.3)

  

(31.3)

  

Chronic pyelonephritis

   

1

6

19

35

90

133

170

191

251

353

494

466

372

261

150

42

7

3041

1

 

3042

65.46

13.88

(%)

   

(0.9)

(2.4)

(2.8)

(2.0)

(2.2)

(1.5)

(1.3)

(1.1)

(1.0)

(0.9)

(0.9)

(0.9)

(0.9)

(0.8)

(0.9)

(1.0)

(1.1)

(1.0)

(4.8)

 

(1.0)

  

RPGN

 

2

  

5

12

18

36

67

91

103

151

277

381

438

391

317

165

35

5

2494

  

2494

68.92

12.99

(%)

 

(6.3)

  

(2.0)

(1.8)

(1.0)

(0.9)

(0.8)

(0.7)

(0.6)

(0.6)

(0.7)

(0.7)

(0.9)

(0.9)

(1.0)

(1.0)

(0.8)

(0.8)

(0.8)

  

(0.8)

  

PIH

      

7

11

50

83

124

163

305

342

270

166

71

20

2

 

1614

  

1614

64.49

10.24

(%)

      

(0.4)

(0.3)

(0.6)

(0.6)

(0.7)

(0.6)

(0.8)

(0.7)

(0.5)

(0.4)

(0.2)

(0.1)

(0.0)

 

(0.5)

  

(0.5)

  

Unclassified nephritis

1

2

6

6

21

29

42

69

94

109

106

113

142

143

185

136

96

51

19

3

1373

  

1373

60.35

17.10

(%)

(2.4)

(6.3)

(13.6)

(5.5)

(8.5)

(4.3)

(2.4)

(1.7)

(1.1)

(0.8)

(0.6)

(0.4)

(0.4)

(0.3)

(0.4)

(0.3)

(0.3)

(0.3)

(0.4)

(0.5)

(0.4)

  

(0.4)

  

PKD

5

2

 

3

6

12

30

94

288

576

930

1274

1891

1980

1640

1177

727

299

62

10

11,006

  

11,006

65.01

11.29

(%)

(12.2)

(6.3)

 

(2.8)

(2.4)

(1.8)

(1.7)

(2.3)

(3.4)

(4.3)

(5.2)

(5.0)

(4.7)

(3.8)

(3.3)

(2.8)

(2.3)

(1.8)

(1.4)

(1.6)

(3.5)

  

(3.5)

  

Nephrosclerosis

  

2

2

12

29

60

144

389

611

745

1209

2092

3258

4221

5003

5469

3625

1244

182

28,297

1

 

28,298

73.99

11.76

(%)

  

(4.5)

(1.8)

(4.9)

(4.3)

(3.4)

(3.6)

(4.5)

(4.6)

(4.2)

(4.8)

(5.2)

(6.2)

(8.6)

(11.8)

(17.0)

(21.8)

(28.4)

(29.4)

(9.1)

(4.8)

 

(9.1)

  

Hypertensive emergencies

    

3

9

44

94

150

188

217

220

294

332

305

272

250

143

43

9

2573

  

2573

64.20

14.83

(%)

    

(1.2)

(1.3)

(2.5)

(2.3)

(1.7)

(1.4)

(1.2)

(0.9)

(0.7)

(0.6)

(0.6)

(0.6)

(0.8)

(0.9)

(1.0)

(1.5)

(0.8)

  

(0.8)

  

Diabetes

2

1

2

8

7

35

313

1048

2859

4831

7042

10,197

16,451

22,304

20,127

16,494

10,789

4570

901

98

118,079

2

 

118,081

67.33

11.28

(%)

(4.9)

(3.1)

(4.5)

(7.3)

(2.8)

(5.1)

(17.7)

(26.0)

(33.3)

(36.3)

(39.3)

(40.2)

(40.8)

(42.7)

(40.8)

(39.0)

(33.6)

(27.4)

(20.5)

(15.9)

(38.1)

(9.5)

 

(38.1)

  

Lupus

  

1

5

9

24

41

80

138

207

214

261

298

324

244

202

116

61

10

1

2236

  

2236

60.73

13.97

(%)

  

(2.3)

(4.6)

(3.7)

(3.5)

(2.3)

(2.0)

(1.6)

(1.6)

(1.2)

(1.0)

(0.7)

(0.6)

(0.5)

(0.5)

(0.4)

(0.4)

(0.2)

(0.2)

(0.7)

  

(0.7)

  

Amyloidosis

       

4

19

19

27

27

56

77

86

70

47

15

4

 

451

  

451

67.50

11.65

(%)

       

(0.1)

(0.2)

(0.1)

(0.2)

(0.1)

(0.1)

(0.1)

(0.2)

(0.2)

(0.1)

(0.1)

(0.1)

 

(0.1)

  

(0.1)

  

Gout

     

1

3

8

29

40

68

82

152

201

207

181

96

39

4

1

1112

1

 

1113

67.56

11.06

(%)

     

(0.1)

(0.2)

(0.2)

(0.3)

(0.3)

(0.4)

(0.3)

(0.4)

(0.4)

(0.4)

(0.4)

(0.3)

(0.2)

(0.1)

(0.2)

(0.4)

(4.8)

 

(0.4)

  

Inborn errors of metabolism

2

  

5

10

17

19

29

39

30

17

23

27

23

13

7

4

7

  

272

  

272

48.99

16.94

(%)

(4.9)

  

(4.6)

(4.1)

(2.5)

(1.1)

(0.7)

(0.5)

(0.2)

(0.1)

(0.1)

(0.1)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

  

(0.1)

  

(0.1)

  

Tuberculosis

         

1

4

9

19

47

54

20

37

10

5

 

206

  

206

72.33

8.75

(%)

         

(0.0)

(0.0)

(0.0)

(0.0)

(0.1)

(0.1)

(0.0)

(0.1)

(0.1)

(0.1)

 

(0.1)

  

(0.1)

  

Urolithiasis

      

1

3

8

11

26

44

60

97

103

94

85

38

10

1

581

  

581

70.48

11.08

(%)

      

(0.1)

(0.1)

(0.1)

(0.1)

(0.1)

(0.2)

(0.1)

(0.2)

(0.2)

(0.2)

(0.3)

(0.2)

(0.2)

(0.2)

(0.2)

  

(0.2)

  

Neoplasm of kidney and urinary tract

   

1

 

1

3

7

7

11

19

39

76

139

173

154

174

62

17

3

886

  

886

72.53

10.68

(%)

   

(0.9)

 

(0.1)

(0.2)

(0.2)

(0.1)

(0.1)

(0.1)

(0.2)

(0.2)

(0.3)

(0.4)

(0.4)

(0.5)

(0.4)

(0.4)

(0.5)

(0.3)

  

(0.3)

  

Urinary tract obstructive

1

 

1

 

3

9

27

42

41

43

42

32

66

90

102

89

88

36

10

 

722

1

 

723

63.81

16.72

(%)

(2.4)

 

(2.3)

 

(1.2)

(1.3)

(1.5)

(1.0)

(0.5)

(0.3)

(0.2)

(0.1)

(0.2)

(0.2)

(0.2)

(0.2)

(0.3)

(0.2)

(0.2)

 

(0.2)

(4.8)

 

(0.2)

  

Myeloma

   

2

  

1

1

6

6

10

12

29

51

50

43

38

22

2

3

276

  

276

70.55

12.17

(%)

   

(1.8)

  

(0.1)

(0.0)

(0.1)

(0.0)

(0.1)

(0.0)

(0.1)

(0.1)

(0.1)

(0.1)

(0.1)

(0.1)

(0.0)

(0.5)

(0.1)

  

(0.1)

  

Hypoplastic kidney

10

11

13

21

29

47

71

94

72

67

38

29

30

34

32

26

15

6

4

 

649

  

649

44.24

19.08

(%)

(24.4)

(34.4)

(29.5)

(19.3)

(11.8)

(6.9)

(4.0)

(2.3)

(0.8)

(0.5)

(0.2)

(0.1)

(0.1)

(0.1)

(0.1)

(0.1)

(0.0)

(0.0)

(0.1)

 

(0.2)

  

(0.2)

  

Undetermined

2

 

2

11

23

69

185

382

712

992

1236

1757

2937

3907

4152

4201

3732

2418

698

114

27,530

14

 

27,544

69.80

13.13

(%)

(4.9)

 

(4.5)

(10.1)

(9.3)

(10.1)

(10.5)

(9.5)

(8.3)

(7.5)

(6.9)

(6.9)

(7.3)

(7.5)

(8.4)

(9.9)

(11.6)

(14.5)

(15.9)

(18.4)

(8.9)

(66.7)

 

(8.9)

  

Rejected kidney

  

2

1

12

22

64

91

181

240

315

367

332

257

115

73

58

22

10

1

2163

  

2163

56.37

12.59

(%)

  

(4.5)

(0.9)

(4.9)

(3.2)

(3.6)

(2.3)

(2.1)

(1.8)

(1.8)

(1.4)

(0.8)

(0.5)

(0.2)

(0.2)

(0.2)

(0.1)

(0.2)

(0.2)

(0.7)

  

(0.7)

  

Others

17

10

9

15

29

105

153

208

305

393

443

529

785

1000

1097

1014

844

454

126

20

7556

1

 

7557

65.60

15.70

(%)

(41.5)

(31.3)

(20.5)

(13.8)

(11.8)

(15.4)

(8.7)

(5.2)

(3.5)

(3.0)

(2.5)

(2.1)

(1.9)

(1.9)

(2.2)

(2.4)

(2.6)

(2.7)

(2.9)

(3.2)

(2.4)

(4.8)

 

(2.4)

  

Subtotal

41

32

44

109

246

682

1764

4025

8596

13,305

17,913

25,350

40,352

52,259

49,367

42,251

32,087

16,659

4387

618

310,087

21

 

310,108

67.54

12.49

(%)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

(100.0)

 

(100.0)

  

No information available

(%)

                          

Total

41

32

44

109

246

682

1764

4025

8596

13,305

17,913

25,350

40,352

52,259

49,367

42,251

32,087

16,659

4387

618

310,087

21

 

310,108

67.54

12.49

(%)

                          
  1. Values in parentheses under each figure represent the percentage relative to the subtotal in each row
  2. The column “No information on birth date” shows the number of patients who provided no date of birth; thus, the calculation of age was impossible
  3. RPGN Rapidly progressive glomerulonephritis, PIH Pregnancy-induced hypertension, PKD polycystic kidney disease